Back to Results
First PageMeta Content
Biotechnology / Ampakines / Business / Cortex Pharmaceuticals / Gilead Sciences / Bristol-Myers Squibb / Technology


  Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors; Expands Board to Five Members James E. Sapirstein and Kathryn MacFarlane join the Board of Directors
Add to Reading List

Document Date: 2014-09-05 11:43:04


Open Document

File Size: 131,53 KB

Share Result on Facebook